Matches in SemOpenAlex for { <https://semopenalex.org/work/W3104448717> ?p ?o ?g. }
- W3104448717 endingPage "330" @default.
- W3104448717 startingPage "320" @default.
- W3104448717 abstract "Sulindac has shown significant clinical benefit in preventing colorectal cancer progression, but its mechanism of action has not been fully elucidated. We have found that sulindac sulfide (SS) is able to inhibit cell cycle progression in human colorectal cancer cells, particularly through G1 arrest. To understand the underlying mechanisms of sulindac inhibitory activity, we have demonstrated that Cyclin G2 up-regulation upon SS treatment can substantially delay cell cycle progression by enhancing the transcriptional activity of FOXO3a in human colorectal tumor cells. MiR-182, an oncogenic microRNA known to inhibit FOXO3a gene expression, is also involved in the suppressive effect of SS on cell cycle progression. This process begins with the down-regulation of miR-182, followed by the enhancement of FOXO3a transcriptional activity and the up-regulation of Cyclin G2. To further determine the clinical utility of this axis, we analyzed the expression of miR-182/FOXO3a/Cyclin G2 in human colorectal tumor samples. Our results show not only that there are significant differences in miR-182/FOXO3a/Cyclin G2 between tumors and normal tissues, but also that the synergetic effect of miR-182 and FOXO3a is associated with predicting tumor progression. Our study demonstrates a novel mechanistic axis consisting of miR-182/FOXO3a/Cyclin G2 that mediates sulindac inhibition of cell cycle progression." @default.
- W3104448717 created "2020-11-23" @default.
- W3104448717 creator A5011390866 @default.
- W3104448717 creator A5030129271 @default.
- W3104448717 creator A5038625195 @default.
- W3104448717 creator A5067857414 @default.
- W3104448717 creator A5069340040 @default.
- W3104448717 creator A5084369103 @default.
- W3104448717 creator A5087841432 @default.
- W3104448717 date "2021-05-01" @default.
- W3104448717 modified "2023-09-26" @default.
- W3104448717 title "Cyclin G2, a novel target of sulindac to inhibit cell cycle progression in colorectal cancer" @default.
- W3104448717 cites W1648301895 @default.
- W3104448717 cites W1965532883 @default.
- W3104448717 cites W1969167680 @default.
- W3104448717 cites W1970602112 @default.
- W3104448717 cites W2000555456 @default.
- W3104448717 cites W2008590315 @default.
- W3104448717 cites W2012801178 @default.
- W3104448717 cites W2024233889 @default.
- W3104448717 cites W2026650776 @default.
- W3104448717 cites W2029005353 @default.
- W3104448717 cites W2034201098 @default.
- W3104448717 cites W2045574895 @default.
- W3104448717 cites W2046024621 @default.
- W3104448717 cites W2049834612 @default.
- W3104448717 cites W2080126338 @default.
- W3104448717 cites W2080436457 @default.
- W3104448717 cites W2081920683 @default.
- W3104448717 cites W2100910673 @default.
- W3104448717 cites W2107277218 @default.
- W3104448717 cites W2111263798 @default.
- W3104448717 cites W2117692326 @default.
- W3104448717 cites W2127849907 @default.
- W3104448717 cites W2129193589 @default.
- W3104448717 cites W2131237486 @default.
- W3104448717 cites W2134185120 @default.
- W3104448717 cites W2149772130 @default.
- W3104448717 cites W2156470937 @default.
- W3104448717 cites W2161176810 @default.
- W3104448717 cites W2161659436 @default.
- W3104448717 cites W2162275477 @default.
- W3104448717 cites W2165178639 @default.
- W3104448717 cites W2165907987 @default.
- W3104448717 cites W2286081257 @default.
- W3104448717 cites W2336215030 @default.
- W3104448717 cites W2535123971 @default.
- W3104448717 cites W2631953575 @default.
- W3104448717 cites W2999417355 @default.
- W3104448717 cites W376861644 @default.
- W3104448717 doi "https://doi.org/10.1016/j.gendis.2020.11.006" @default.
- W3104448717 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8093647" @default.
- W3104448717 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33997179" @default.
- W3104448717 hasPublicationYear "2021" @default.
- W3104448717 type Work @default.
- W3104448717 sameAs 3104448717 @default.
- W3104448717 citedByCount "5" @default.
- W3104448717 countsByYear W31044487172021 @default.
- W3104448717 countsByYear W31044487172022 @default.
- W3104448717 countsByYear W31044487172023 @default.
- W3104448717 crossrefType "journal-article" @default.
- W3104448717 hasAuthorship W3104448717A5011390866 @default.
- W3104448717 hasAuthorship W3104448717A5030129271 @default.
- W3104448717 hasAuthorship W3104448717A5038625195 @default.
- W3104448717 hasAuthorship W3104448717A5067857414 @default.
- W3104448717 hasAuthorship W3104448717A5069340040 @default.
- W3104448717 hasAuthorship W3104448717A5084369103 @default.
- W3104448717 hasAuthorship W3104448717A5087841432 @default.
- W3104448717 hasBestOaLocation W31044487171 @default.
- W3104448717 hasConcept C104317684 @default.
- W3104448717 hasConcept C11882975 @default.
- W3104448717 hasConcept C120089663 @default.
- W3104448717 hasConcept C120504264 @default.
- W3104448717 hasConcept C121608353 @default.
- W3104448717 hasConcept C126322002 @default.
- W3104448717 hasConcept C145059251 @default.
- W3104448717 hasConcept C16438837 @default.
- W3104448717 hasConcept C199835354 @default.
- W3104448717 hasConcept C2776241388 @default.
- W3104448717 hasConcept C2778437423 @default.
- W3104448717 hasConcept C2778484676 @default.
- W3104448717 hasConcept C2779256057 @default.
- W3104448717 hasConcept C29537977 @default.
- W3104448717 hasConcept C2994037739 @default.
- W3104448717 hasConcept C502942594 @default.
- W3104448717 hasConcept C526805850 @default.
- W3104448717 hasConcept C54355233 @default.
- W3104448717 hasConcept C62112901 @default.
- W3104448717 hasConcept C71924100 @default.
- W3104448717 hasConcept C86803240 @default.
- W3104448717 hasConcept C94561458 @default.
- W3104448717 hasConcept C9743823 @default.
- W3104448717 hasConcept C98274493 @default.
- W3104448717 hasConceptScore W3104448717C104317684 @default.
- W3104448717 hasConceptScore W3104448717C11882975 @default.
- W3104448717 hasConceptScore W3104448717C120089663 @default.
- W3104448717 hasConceptScore W3104448717C120504264 @default.
- W3104448717 hasConceptScore W3104448717C121608353 @default.